Tuesday, July 19, 2016

BRIEF-Sciclone Pharmaceuticals plans to remain independent publicly traded company

* No longer continuing active discussions with potential

acquirers

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)